Latest filing published 08 Apr 2026 for Shanghai Junshi Biosciences Co., Ltd., €7.7M.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -26.1%Entry HK$25.04 · Close at T+90 HK$18.50
- -18.3%Entry HK$21.90 · Close 05 Oct 2026 HK$17.90
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Xiong Jun: trading record in brief
Xiong Jun is a declared insider of Shanghai Junshi Biosciences Co., Ltd. (chief executive), with filings sourced from HKEX. In total, 3 filings cover trades dated from 16 March 2026 to 31 March 2026.
No open-market sale appears; the market trades are 3 purchases worth €10.7M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
In size, the median ticket on the buying side is €2.1M. Measured against the company's value, the median purchase equals 0.10% of market capitalisation, across 3 purchases where it is known. None of the 3 purchases we analysed coincided with buying by another insider of the same company within 30 days. Ninety days after publication, 3 purchases show a median change of -26.1%, with the price up in 0% of them. This is a record of the past, not a forecast.
On 8 April 2026 came the latest disclosure, an open-market purchase for €7.7M in Shanghai Junshi Biosciences Co., Ltd. Between a trade and the moment it shows up on HKEX, the median delay is 8 days. This delay matters because a trade only becomes useful information once it is public. Source: insider filings from HKEX. Past trades are no guide to future returns.
Companies and markets linked to Xiong Jun
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,999,513 shares@ HK$34.81150.37% mcap71.8% of flowShareXHKGHKEX:DA20260403E00020Canonical exit: 29 Jun 2026 (T+90)
- 894,600 shares@ HK$21.04340.10% mcap19.4% of flowShareXHKGHKEX:DA20260403E00021Canonical exit: 29 Jun 2026 (T+90)
- 265,382 shares@ HK$31.53260.045% mcap8.8% of flowShareXHKGHKEX:DA20260319E00117Canonical exit: 14 Jun 2026 (T+90)
3 of 3 declarations